SCIENTURE’S Arbli™ Becomes First FDA-Approved Ready-to-Use Liquid Losartan Available Through Major U.S. Wholesalers

Novel oral suspension addresses critical patient safety needs for hypertension treatment for patients unable to swallow tablets

U.S. losartan market totals $256M annually with 71M prescriptions, creating a significant opportunity for Arbli^™ as the first FDA-approved ready-to-use oral suspension

Read more at globenewswire.com